Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.34
-6.77 (-3.22%)
AAPL  266.97
+2.39 (0.90%)
AMD  195.24
-4.91 (-2.45%)
BAC  50.95
-2.11 (-3.97%)
GOOG  313.49
-1.41 (-0.45%)
META  642.20
-13.46 (-2.05%)
MSFT  386.39
-10.84 (-2.73%)
NVDA  190.38
+0.56 (0.30%)
ORCL  138.85
-9.23 (-6.23%)
TSLA  395.94
-15.88 (-3.86%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.